-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $90

Benzinga·11/09/2026 14:04:49
Listen to the news
Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $100 to $90.